Axtria Blogs

Managed Care Organizations

Dirty Data, meet the KAM Braintrust

Talk about famous last words. When we last left this topic, I was wrapping up coffee with my colleague, Rick, with the ominous, “Once we get your data organized …”

Read More

You would think Managed Markets would be more orderly

After I posted my hypothesis that Managed Markets analytics and operational teams were simultaneously more over-whelmed and under-resourced (Blog Series), I had a number of good exchanges with my colleagues, both digitally and IRL.

Read More

Payer Influence on Product Performance in the Pharma Industry

Rebates and Discounts represent one of the largest line items on Financial Statements of Pharmaceutical Manufacturers, yet the criteria for assessing contracting decisions often lacks the analytical rigor that match the financial exposure. Pre-deal analysis uses inputs from account managers which tend to overestimate both the benefit of contracting and the risks associated of not contracting. This is not a surprise since factors beyond Pharma’s control can impact the actual results, including a payer’s formulary control and related spillover impacts.

Read More

Let Us Show You What Axtria’s 

Solutions Can Do For You